Chi Wut Wong

Chi Wut Wong earned his Bachelor of Biomedical Sciences degree from The University of Hong Kong with first-class honors in 2017. Under the supervision of Dr. Aimin Xu, he also investigated the utility of using exosomes as a biomarker for non-alcoholic fatty liver diseases and the relationship between type 2 diabetes and non-alcoholic steatohepatitis. He also studied mechanobiology and applications of cell therapy with Dr. Weian Zhao during his internship at the University of California, Irvine. In 2018, Chi Wut joined the Duke University Graduate School Department of Pharmacology, where he completed his doctoral research under the mentorship of Dr. Xiling Shen and Dr. Jatin Roper. His thesis is titled “Glycerate from Fat-modulating Fructose Metabolism as a Mediator of Diabetes”. He joined TIBI in 2022 as a postdoctoral researcher. His research focuses on using bioinformatic tools and organoid co-culture systems to dissect the cancer microenvironment and evolution.Geetha orchestrates research in the development of biomaterials with intrinsic smart properties, catering to diverse medical applications such as implantology, cancer therapy, drug delivery, theranostics, and more. Her center serves as a breeding ground for cutting-edge technologies, including additive manufacturing for scaffold and implant construction, microfluidics for pain-free drug delivery, small molecule-mediated cancer therapy, nanotechnology-based biosensors, and other innovative advancements. Throughout her tenure at VIT, she has established state-of-the-art biomaterials labs, spearheaded numerous biomaterial projects, and mentored several students & faculties while introducing pioneering courses bridging material science with biomedicine. With over 11,000 citations and an h-index of 37, her publications serve as valuable references for researchers worldwide, contributing to a thriving scientific community focused on knowledge sharing.